Results 241 to 250 of about 13,859,586 (381)

Clinical Observation and Follow-up Study on 226 Cases of Tuberculous Spondylitis [PDF]

, 1967
Hak Hyun Kim, Myung Deuk Rho, In Kim, Jin Ha Park   +3 more
openalex   +1 more source

Detection of relapse in non‐Hodgkin's lymphoma: Role of routine follow‐up studies

American journal of hematology/oncology, 2002
A. Elis, D. Blickstein, Osnat Klein, Rivka Eliav-Ronen, Y. Manor, M. Lishner   +5 more
semanticscholar   +1 more source

Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies. [PDF]

Front Oncol, 2019
Guo M, Liu T, Li P, Wang T, Zeng C, Yang M, Li G, Han J, Wu W, Zhang R.   +9 more
europepmc   +1 more source

Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting

Molecular Oncology, EarlyView.
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé, Lisa Hahnefeld, Katharina J. Wenger, Donat Kögel, Joachim Steinbach, Gerd Geisslinger, Michael W. Ronellenfitsch, Irmgard Tegeder   +7 more
wiley   +1 more source

Initial findings of the follow-up study of child development counselors.

, 1967
Stuart E. Golann
openalex   +2 more sources

Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM

Molecular Oncology, EarlyView.
CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak, Żaneta Zarębska, Marcin P. Sajek, Adriana Grabowska, Alessia Buratin, Paweł Głodowicz, Julia O. Misiorek, Konrad Kuczyński, Stefania Bortoluzzi, Marek Żywicki, Jan G. Kosiński, Agnieszka Rybak‐Wolf, Rafał Piestrzeniewicz, Anna M. Barciszewska, Katarzyna Rolle   +14 more
wiley   +1 more source

Update to analysis of follow-up studies with Stata 5.0 [PDF]

David Clayton, Michael Hills
core  

Targeting the MDM2‐MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer

Molecular Oncology, EarlyView.
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini, Giada Mele, Marika Attili, Maria Rita Assenza, Fulvio Saccoccia, Francesca Sardina, Cinzia Rinaldo, Roberto Massari, Nicola Tirelli, Alfredo Pontecorvi, Fabiola Moretti   +10 more
wiley   +1 more source

PO.6.131 A randomized, double-blind, placebo controlled study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-303, a potent dual baff/april inhibitor, in adult healthy volunteers

Lupus Science and Medicine, 2022
A Smith, P Harrison, S Peng, S Dillon, J Lickliter, K Manjarrez, M Lessig, R Sanderson, A Chunyk, H Zayed   +9 more
doaj   +1 more source

Preinfarctional (Unstable) Angina—A Prospective Study— Ten Year Follow-Up [PDF]

, 1973
Peter C. Gazes, Elizabeth Mobley, Henry M. Faris, Robert Duncan, G. Humphries   +4 more
openalex   +1 more source